Ironwood Pharmaceuticals (IRWD) Cash & Equivalents (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Cash & Equivalents of $220.5 million for Q1 2026, up 2.33% sequentially from $215.5 million in Q4 2025, and up 103.23% YoY from $108.5 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Cash & Equivalents (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Cash & Equivalents for 17 years, with the latest figure at $220.5 million in Q1 2026.
- Quarterly Cash & Equivalents rose 103.23% year-over-year to $220.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220.5 million (up 103.23% YoY) and the FY2025 annual result came in at $215.5 million, up 143.29% from the prior year.
- Cash & Equivalents rose to $220.5 million in Q1 2026 per IRWD's latest filing, from $215.5 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $740.3 million in Q1 2023 and troughed at $88.2 million in Q3 2024.
- A 5-year average of $272.2 million and a median of $140.4 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents plunged 85.96% in 2023, then soared 143.29% in 2025.
- Over 5 years, Cash & Equivalents stood at $656.2 million in 2022, then slumped by 85.96% to $92.2 million in 2023, then slipped by 3.9% to $88.6 million in 2024, then jumped by 143.29% to $215.5 million in 2025, then climbed by 2.33% to $220.5 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $220.5 million, $215.5 million, and $140.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Ironwood Pharmaceuticals | 668.31 Mn | 589.18 Mn | - | 79.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.13 Mn |
| Mar 31, 2026 | 220.47 Mn |
| Dec 31, 2025 | 215.46 Mn |
| Sep 30, 2025 | 140.41 Mn |
| Jun 30, 2025 | 92.85 Mn |
| Mar 31, 2025 | 108.48 Mn |
| Dec 31, 2024 | 88.56 Mn |
| Sep 30, 2024 | 88.21 Mn |
| Jun 30, 2024 | 105.52 Mn |
| Mar 31, 2024 | 121.54 Mn |
| Dec 31, 2023 | 92.15 Mn |
| Sep 30, 2023 | 110.16 Mn |
| Jun 30, 2023 | 175.32 Mn |
| Mar 31, 2023 | 740.34 Mn |
| Dec 31, 2022 | 656.20 Mn |
| Sep 30, 2022 | 574.19 Mn |
| Jun 30, 2022 | 504.37 Mn |
| Mar 31, 2022 | 593.37 Mn |
| Dec 31, 2021 | 620.13 Mn |
| Sep 30, 2021 | 574.28 Mn |